Clari Vest Asset Management LLC Immunity Bio, Inc. Transaction History

Clari Vest Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$4.35 - $6.77 $1,157 - $1,800	-266 Reduced 0.3%	89,642 $454,000
Q3 2022 Nov 10, 2022	SELL	$3.65 - $6.43 $886 - $1,562	-243 Reduced 0.27%	89,908 $447,000
Q2 2022 Aug 12, 2022	BUY	$2.68 - $6.14 $97,616 - $223,643	36,424 Added 67.79%	90,151 $335,000
Q1 2022 May 04, 2022	BUY	$5.05 - $7.53 $74,063 - $110,434	14,666 Added 37.55%	53,727 $302,000
Q4 2021 Feb 14, 2022	SELL	$5.67 - $10.18 $948,426 - $1.7 Million	-167,271 Reduced 81.07%	39,061 $237,000
Q3 2021 Nov 08, 2021	SELL	$9.17 - $14.24 $92,552 - $143,724	-10,093 Reduced 4.66%	206,332 $2.01 Million
Q2 2021 Aug 09, 2021	BUY	$13.41 - $22.4 $2.9 Million - $4.85 Million	216,425 New	216,425 $3.09 Million

202

70M

1.68M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.8B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Clari Vest Asset Management LLC with notifications on news.